ZA836701B - Imidazo(1,2-a)quinolines - Google Patents
Imidazo(1,2-a)quinolinesInfo
- Publication number
- ZA836701B ZA836701B ZA836701A ZA836701A ZA836701B ZA 836701 B ZA836701 B ZA 836701B ZA 836701 A ZA836701 A ZA 836701A ZA 836701 A ZA836701 A ZA 836701A ZA 836701 B ZA836701 B ZA 836701B
- Authority
- ZA
- South Africa
- Prior art keywords
- group
- alkyl group
- image
- formula
- alkoxy
- Prior art date
Links
- HJMONQQZFQKQPS-UHFFFAOYSA-N imidazo[1,2-a]quinoline Chemical class C1=CC=C2N3C=CN=C3C=CC2=C1 HJMONQQZFQKQPS-UHFFFAOYSA-N 0.000 title abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 4
- 125000003545 alkoxy group Chemical group 0.000 abstract 3
- 125000004423 acyloxy group Chemical group 0.000 abstract 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical group ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 239000000460 chlorine Chemical group 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 230000009429 distress Effects 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Anesthesiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Luminescent Compositions (AREA)
Abstract
Imidazo[1,2-a]quinolines of formula I <IMAGE> [wherein R1 represents a hydrogen, chlorine or bromine atom; R2 represents a benzoyl group or a group of formula <IMAGE> or <IMAGE> where R6 and R7 represent alkyl groups, R8 represents a hydrogen atom or an alkyl group and Ph represents a phenyl group; R3 represents a hydrogen atom or an alkyl group; R4 represents an alkoxy, hydroxy, acyloxy or alkyl group; and R5 represents an alkyl group; provided that R1 and R3 do not both represent hydrogen atoms when R2 represents a benzoyl group and R4 represents an alkoxy group] and salts thereof have value in the treatment of anxiety and distress. Intermediates of formula V <IMAGE> (wherein R1, R3 and R5 are as defined above and R4 represents an alkoxy, acyloxy or alkyl group) and salts thereof may be used in their preparation.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8228069 | 1982-10-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA836701B true ZA836701B (en) | 1984-10-31 |
Family
ID=10533302
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA836701A ZA836701B (en) | 1982-10-01 | 1983-09-09 | Imidazo(1,2-a)quinolines |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0107988B1 (en) |
| JP (1) | JPS5978188A (en) |
| AT (1) | ATE28646T1 (en) |
| AU (1) | AU564997B2 (en) |
| CA (1) | CA1206475A (en) |
| DE (1) | DE3372771D1 (en) |
| DK (1) | DK454783A (en) |
| ES (1) | ES8704944A1 (en) |
| FI (1) | FI76335C (en) |
| GB (1) | GB2127824B (en) |
| GR (1) | GR79396B (en) |
| HU (1) | HU189750B (en) |
| IE (1) | IE56052B1 (en) |
| IL (1) | IL69721A (en) |
| PT (1) | PT77436B (en) |
| ZA (1) | ZA836701B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP0700395A2 (en) * | 2007-06-07 | 2009-03-02 | Sanofi Aventis | Substituted [1,2,4] triazolo [1,5-a] quinolines, process for their preparation, pharmaceutical compositions thereof, and intermediates |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1596652A (en) * | 1977-01-20 | 1981-08-26 | Roussel Lab Ltd | Imidazo (1,2-a) quinoline-2-carboxylic acid and derivatives |
| GR76063B (en) * | 1981-04-03 | 1984-08-03 | Roussel Uclaf |
-
1983
- 1983-09-09 ZA ZA836701A patent/ZA836701B/en unknown
- 1983-09-14 IL IL69721A patent/IL69721A/en unknown
- 1983-09-26 JP JP58176548A patent/JPS5978188A/en active Pending
- 1983-09-29 HU HU833389A patent/HU189750B/en not_active IP Right Cessation
- 1983-09-29 EP EP83401914A patent/EP0107988B1/en not_active Expired
- 1983-09-29 GR GR72585A patent/GR79396B/el unknown
- 1983-09-29 AT AT83401914T patent/ATE28646T1/en not_active IP Right Cessation
- 1983-09-29 DE DE8383401914T patent/DE3372771D1/en not_active Expired
- 1983-09-30 CA CA000438135A patent/CA1206475A/en not_active Expired
- 1983-09-30 AU AU19823/83A patent/AU564997B2/en not_active Ceased
- 1983-09-30 FI FI833553A patent/FI76335C/en not_active IP Right Cessation
- 1983-09-30 IE IE2321/83A patent/IE56052B1/en unknown
- 1983-09-30 PT PT77436A patent/PT77436B/en not_active IP Right Cessation
- 1983-09-30 GB GB08326230A patent/GB2127824B/en not_active Expired
- 1983-09-30 ES ES526143A patent/ES8704944A1/en not_active Expired
- 1983-10-03 DK DK454783A patent/DK454783A/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DE3372771D1 (en) | 1987-09-03 |
| GR79396B (en) | 1984-10-22 |
| HU189750B (en) | 1986-07-28 |
| ES8704944A1 (en) | 1987-04-16 |
| IL69721A0 (en) | 1983-12-30 |
| IE832321L (en) | 1984-04-01 |
| GB2127824B (en) | 1986-02-12 |
| FI76335B (en) | 1988-06-30 |
| ES526143A0 (en) | 1987-04-16 |
| EP0107988A3 (en) | 1985-05-22 |
| FI833553L (en) | 1984-04-02 |
| AU564997B2 (en) | 1987-09-03 |
| EP0107988B1 (en) | 1987-07-29 |
| GB2127824A (en) | 1984-04-18 |
| IE56052B1 (en) | 1991-03-27 |
| AU1982383A (en) | 1984-04-05 |
| PT77436B (en) | 1986-04-17 |
| DK454783D0 (en) | 1983-10-03 |
| FI76335C (en) | 1988-10-10 |
| CA1206475A (en) | 1986-06-24 |
| ATE28646T1 (en) | 1987-08-15 |
| IL69721A (en) | 1987-03-31 |
| DK454783A (en) | 1984-04-02 |
| EP0107988A2 (en) | 1984-05-09 |
| JPS5978188A (en) | 1984-05-04 |
| PT77436A (en) | 1983-10-01 |
| GB8326230D0 (en) | 1983-11-02 |
| FI833553A0 (en) | 1983-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL216409A1 (en) | ||
| HK30581A (en) | Process for the preparation of 6,6-oxy bis [4-halo-2h-pyran-3(6h)-ones] and their use in preparing gamma-pyrones | |
| GB2151624B (en) | Imidazo1 2-cpyrimidine | |
| GB2127824B (en) | Imidazo(1,2-a)quinolines | |
| ES8402589A1 (en) | 5,6,7,8-Tetrahydro-1,6 naphthyridine derivatives and their preparation | |
| GR76063B (en) | ||
| EP0217737A3 (en) | Tetrahydro-beta-carbolines, process for their preparation and their use as medicaments | |
| PL235882A1 (en) | ||
| IE812975L (en) | Use of azolylglycols as plant growth regulants | |
| ES482280A1 (en) | Imidazolylethoxy derivatives of pyrazolo{8 3,4-b{9 pyridine-5-methanols | |
| ES8504688A1 (en) | Halogenoalkylcarbamic-acid esters, their preparation and their use as pesticides. | |
| GB2071093B (en) | Benzothiopyrano(2,3-c)pyridines | |
| JPS52144696A (en) | Novel pyrido (2,3-d) pyprole (1,2-a) pyrimidine derivatives |